Dupont Capital Management Corp Gilead Sciences, Inc. Transaction History

Dupont Capital Management Corp

$1.18 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 28, 2023	SELL	$77.31 - $88.08 $234,635 - $267,322	-3,035 Reduced 24.88%	9,162 $760,000
Q4 2022 Jan 26, 2023	BUY	$62.32 - $89.47 $149,754 - $214,996	2,403 Added 24.54%	12,197 $0
Q3 2022 Oct 31, 2022	BUY	$59.54 - $68.01 $23,161 - $26,455	389 Added 4.14%	9,794 $604,000
Q2 2022 Jul 26, 2022	SELL	$57.72 - $65.01 $87,099 - $98,100	-1,509 Reduced 13.83%	9,405 $581,000
Q1 2022 Apr 27, 2022	SELL	$57.92 - $72.58 $240,599 - $301,497	-4,154 Reduced 27.57%	10,914 $649,000
Q4 2021 Jan 31, 2022	SELL	$64.88 - $73.64 $499,186 - $566,586	-7,694 Reduced 33.8%	15,068 $1.09 Million
Q3 2021 Nov 03, 2021	SELL	$67.69 - $73.03 $1.76 Million - $1.9 Million	-26,064 Reduced 53.38%	22,762 $1.59 Million
Q2 2021 Jul 30, 2021	BUY	$63.47 - $69.35 $625,687 - $683,652	9,858 Added 25.3%	48,826 $3.36 Million
Q1 2021 Apr 29, 2021	BUY	$60.0 - $68.46 $675,420 - $770,654	11,257 Added 40.62%	38,968 $2.52 Million
Q4 2020 Jan 28, 2021	SELL	$56.65 - $64.55 $104,689 - $119,288	-1,848 Reduced 6.25%	27,711 $1.61 Million
Q3 2020 Oct 29, 2020	SELL	$62.1 - $78.08 $297,521 - $374,081	-4,791 Reduced 13.95%	29,559 $1.87 Million
Q2 2020 Jul 24, 2020	SELL	$72.34 - $84.0 $1.07 Million - $1.25 Million	-14,855 Reduced 30.19%	34,350 $2.64 Million
Q1 2020 Apr 29, 2020	BUY	$62.63 - $80.22 $489,015 - $626,357	7,808 Added 18.86%	49,205 $3.68 Million
Q4 2019 Jan 27, 2020	BUY	$61.62 - $67.78 $312,783 - $344,051	5,076 Added 13.98%	41,397 $2.69 Million
Q3 2019 Oct 28, 2019	SELL	$62.51 - $69.0 $311,112 - $343,413	-4,977 Reduced 12.05%	36,321 $2.3 Million
Q2 2019 Jul 30, 2019	BUY	$61.87 - $69.38 $884,802 - $992,203	14,301 Added 52.97%	41,298 $2.79 Million
Q1 2019 Apr 30, 2019	BUY	$62.53 - $70.05 $545,199 - $610,765	8,719 Added 47.7%	26,997 $1.76 Million
Q4 2018 Feb 01, 2019	SELL	$60.54 - $79.0 $685,373 - $894,359	-11,321 Reduced 38.25%	18,278 $1.14 Million
Q3 2018 Nov 05, 2018	BUY	$71.28 - $78.92 $1.02 Million - $1.12 Million	14,252 Added 92.87%	29,599 $2.29 Million
Q2 2018 Jul 30, 2018	SELL	$64.88 - $75.68 $136,442 - $159,155	-2,103 Reduced 12.05%	15,347 $1.09 Million
Q1 2018 May 02, 2018	SELL	$72.84 - $88.8 $1.85 Million - $2.26 Million	-25,452 Reduced 59.33%	17,450 $1.32 Million
Q4 2017 Jan 31, 2018	SELL	$71.15 - $83.52 $15.1 Million - $17.7 Million	-212,183 Reduced 83.18%	42,902 $3.07 Million
Q3 2017 Oct 31, 2017	BUY	$72.11 - $85.47 $18.4 Million - $21.8 Million	255,085	255,085 $20.7 Million

Others Institutions Holding GILD

# of Institutions

1,931

Shares Held

991M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$10.8 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.4 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$6.88 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.55 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.41 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.

Account